Zebra Capital Management LLC Insulet Corp Transaction History

Zebra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$159.17 - $224.73 $204,374 - $288,553	-1,284 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$130.01 - $216.44 $166,932 - $277,908	1,284 New	1,284 $213,000
Q3 2019 Nov 14, 2019	SELL	$117.35 - $167.95 $297,364 - $425,585	-2,534 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$82.13 - $120.73 $33,755 - $49,620	411 Added 19.36%	2,534 $303,000
Q1 2019 May 15, 2019	BUY	$72.44 - $101.87 $153,790 - $216,270	2,123 New	2,123 $202,000

612

62.9M

339K

916K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $13.7B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Zebra Capital Management LLC with notifications on news.